Certolizumab pegol Terminated Phase 4 Trials for Crohns Disease

IndicationsStatusPurposePhase
TerminatedNot Available4
clinicaltrials.gov IdentifierTitleDrugs
NCT01582568EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment